Arcadi have spent a shipload on the phase III, they must have felt pretty confident in a good result. Good luck all, especially those this drug will help, and any investor who invested in Alchemia’s phase III trial some years back. At least this one isn’t being trialled in Russia
Share Price, page-116
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.20 |
Change
1.140(5.98%) |
Mkt cap ! $2.579B | |||
| Open | High | Low | Value | Volume |
| $19.58 | $20.52 | $19.47 | $9.631M | 477.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 181 | $20.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.24 | 245 | 1 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.21 |
Change
1.140 ( 5.70 %) |
||||
| Open | High | Low | Volume | ||
| $19.56 | $20.51 | $19.53 | 123739 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| NEU (ASX) Chart |